Clinical Trial Update: Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) [Phase 2]

View source ↗

Summary

This update covers an ongoing Phase 2 clinical trial (INTUITT-NF2) evaluating targeted therapies for NF2-related schwannomatosis. The study includes patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma
• Meningioma
• Neurofibromatosis Type
• Schwannoma
• Vestibular Schwannoma

Snippet

Sponsor: Scott R. Plotkin, MD, PhD | Conditions: Neurofibromatosis Type 2, Vestibular Schwannoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING